Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 8/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | CKS1B | P61024 | 1/20 | 0.36 |
| ▸ | SKP1 | P63208 | 1/20 | 0.36 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.36 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30783303 | 0.86 | APP (0.35) | ADORA1ADORA2ACYP11B1CKS1BSKP1 | |
| SCHEMBL721818 | 0.78 | TDO2 (0.39) | ADORA1ADORA2ATDO2NPC1RAB9A | |
| SCHEMBL10339628 | 0.76 | MAPT (0.44) | KMT2AALOX15MEN1NPC1RAB9A | |
| SCHEMBL714013 | 0.74 | ALDH1A1 (0.41) | TDO2KMT2AMEN1NPC1RAB9A | |
| SCHEMBL4934230 | 0.72 | DCUN1D1 (0.40) | TDO2KMT2AMEN1NPC1RAB9A | |
| SCHEMBL21167228 | 0.70 | CDK5 (0.42) | ADORA2ATDO2KMT2AALOX15MEN1 | |
| SCHEMBL7213630 | 0.70 | ALOX15 (0.48) | ADORA1ADORA2ACKS1BSKP1SKP2 | |
| SCHEMBL1821593 | 0.70 | ADORA1 (0.44) | ADORA1ADORA2ACKS1BSKP1SKP2 | |
| SCHEMBL10300877 | 0.70 | ADORA2A (0.50) | ADORA1ADORA2ACYP11B1CYP11B2CKS1B | |
| SCHEMBL23055925 | 0.68 | MAPK1 (0.44) | TDO2KMT2AMEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11117910-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and organic light-emitting apparatus including the organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-09-14 | — | — | US | disclosed |
| US-20190218240-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND ORGANIC LIGHT-EMITTING APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11117910-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and organic light-emitting apparatus including the organic light-emitting device | OCIAD1, LEF1, OXA1L | ADORA1 3748/4885ADORA2A 4732/4885CYP11B1 467/4885 |
| US-20190218240-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND ORGANIC LIGHT-EMITTING APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | OCIAD1, LEF1, OXA1L | ADORA1 3748/4885ADORA2A 4732/4885CYP11B1 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.